Helicos (HLCS) Receives $1000 Award From the National Human Genome Research Institute
More News related to HLCS
- Helicos BioSciences (HLCS) Sells Genetic Analysis System to Dutch Research Collaborative
- Helicos BioSciences Announces the Sale of a Helicos(R) Genetic Analysis System to the Leiden University Medical Center in the Netherlands
- Unusual 11 Mid-Day Movers 11/11: NCST, SMI, MSN, CHLN Higher; TONE, RHIE, CLWR, STV Lower
- Helicos BioSciences (HLCS) Files $50M Shelf Registration
- Helicos BioSciences (HLCS) Announces Filing of 10-Q; Disengages in Sale of Company
More News related to Corporate News
- BMO Capital Upgrades The Pantry (PTRY) to Outperform
- Amylin Pharmaceuticals (AMLN): Upgraded to Overweight at Barclays, target raised to $22
- Barclays Upgrades Amylin Pharmaceuticals (AMLN) to Overweight
- Oppenheimer Upgrades Acuity Brands (AYI) to Outperform
- Jefferies & Co Upgrades Cephalon (CEPH) to Buy
Helicos BioSciences Corporation (Nasdaq: HLCS) announced today the reception of $1000 from the National Human Genome Research Institute (NHGRI).
The award is part of a two year grant for the Sequencing Technology Development Program representing NHGRI's Signature Project for the American Recovery and Reinvestment Act's effort to jump start the economy and create or save millions of jobs. The grant's total award is $2.9 million.
The Helicos Genetic Analysis System is the world's first and only commercially available, single molecule sequencing technology.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
